Pensionfund Dsm Netherlands Regeneron Pharmaceuticals, Inc. Transaction History

Pensionfund Dsm Netherlands

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$595.12 - $698.43 $952,192 - $1.12 Million	-1,600 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$574.03 - $680.96 $918,448 - $1.09 Million	1,600 New	1,600 $968,000
Q2 2019 Jul 02, 2019	SELL	$299.6 - $414.82 $1.86 Million - $2.57 Million	-6,200 Closed	0 $0
Q1 2019 Apr 01, 2019	SELL	$372.08 - $439.57 $186,040 - $219,785	-500 Reduced 7.46%	6,200 $2.55 Million
Q4 2018 Jan 02, 2019	BUY	$335.82 - $403.04 $2.25 Million - $2.7 Million	6,700 New	6,700 $2.5 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Pensionfund Dsm Netherlands, based on Form 13F filings with the SEC.

Stay updated on Pensionfund Dsm Netherlands with notifications on news.